Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/124247
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer |
Author: | Tan, J.L. Mugwagwa, A.N. Cieslik, L. Joshi, R. |
Citation: | BMJ Case Reports, 2019; 12(7):229963-1-229963-5 |
Publisher: | BMJ Publishing Group |
Issue Date: | 2019 |
ISSN: | 1757-790X 1757-790X |
Statement of Responsibility: | Jin Lin Tan, Augustine Nyasha Mugwagwa, Luke Cieslik, Rohit Joshi |
Abstract: | We report a case of a 74-year-old man who developed myocarditis complicated by atrioventricular (AV) block following two doses of nivolumab for the treatment of non-small cell lung cancer. A diagnosis of drug-induced acute myocarditis with complete AV block was considered on the basis of elevated troponin, new onset left ventricular (LV) systolic dysfunction, absence of acute myocardial infarction and some findings suggestive of myocarditis on cardiac magnetic resonance. The patient was commenced on glucocorticoids, perindopril and carvedilol. AV block and LV dysfunction persisted despite 2 weeks of treatment. He ultimately became hypotensive which prompted an implantation of a cardiac resynchronisation therapy pacemaker. Follow-up echocardiogram at 6 weeks showed resolution of LV systolic dysfunction. However, he continued to have AV block. |
Keywords: | arrhythmias drugs and medicines lung cancer (oncology) |
Rights: | © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ. |
DOI: | 10.1136/bcr-2019-229963 |
Published version: | http://dx.doi.org/10.1136/bcr-2019-229963 |
Appears in Collections: | Aurora harvest 8 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.